Finland: Three biotechs join forces to form international diagnostics competitor

CEOs of Abacus Diagnostica, Kaivogen and Labrox

Three Finnish biotech companies – Abacus Diagnostica, Kaivogen and Labrox – are joining forces to form an international player in in vitro diagnostics. The new company, which has yet to be named, will provide a total solution for point-of-care testing, including diagnostics for infectious diseases and cancers. It will offer healthcare providers and patients faster, easier…

You must be a HMI Subscriber to view this content.

Subscribe Now »